دورية أكاديمية

Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies

التفاصيل البيبلوغرافية
العنوان: Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies
المؤلفون: Rondy M., Kissling E., Emborg H. -D., Gherasim A., Pebody R., Trebbien R., Pozo F., Larrauri A., McMenamin J., Valenciano M., Kaic B., Filipovic S. K., Visekruna-Vucina V., Novosel I. P., Lovric Z., Petrovic G., Krause T. G., Fische T. K., Lina B., Falchi A., Vilcu A. -M., Souty C., Blanchon T., van der Werf S., Enouf V., Behillil S., Valette M., Bernard-Stoecklin S., Levy-Bruhl D., Launay O., Loulergue P., Lenzi N., Lesieur Z., L'Honneur A. -S., Galtier F., Agostini C., Serrand C., Merle C., Foulongne V., Vanhems P., Laine F., Lagathu G., Carrat F., Buda S., Preuss U., Prahm K., Schweiger B., Wedde M., Heider A., Martin M., Biere B., Duerrwald R., Domegan L., Coughlan L., O'Donnell J., Joyce M., Collins C., Dunford L., Moran J., Tuite G., Duffy M., Connell J., de Gascun C., Rizzo C., Bella A., Alfonsi V., Castrucci M. R., Puzelli S., Pagani E., Ghisetti V., Pariani E., Baldanti F., Palu G., D'Agaro P., Ansaldi F., Affanni P., Rossolini G. M., Camilloni B., Bagnarelli P., Sanguinetti M., Atripaldi L., Chironna M., Serra C., Vitale F., Germinario C., Orsi A., Manini I., Montomoli E., Napoli C., Orsi G. B., Casado I., Castilla J., Fernandino L., Martinez-Baz I., Ezpeleta G., Navascues A., Perez-Garcia A., Aguinaga A., Ezpeleta C., Meijer A., van den Brink S., van der Hoek W., Goderski G., Wijsman L., Bagheri M., Dijkstra F., de Lange M., Marzec T., Overduin P., Teirlinck A., Wentink E., Donker G., Marbus S., van Gageldonk-Lafeber R., Schneeberger P., van Oosterheert J. J., Schweitzer V., Groeneveld G., Nunes B., Machado A., Rodrigues A. P., Gomez V., Kislaya I., Guiomar R., Pechirra P., Cristovao P., Costa I., Panarra A., Corte-Real R., Pocas J., Peres M. J., Comas L. G., Marisquerena M. E. I., Galan J. C., Folgueira M. D., Carril F. G., Martinez R. S., Cilla G., Cenoz M. G., Rubio C. Q., Ochoa E. M., Blasco M., Duran J. G., Vanrell J. M., Reina J., Castrillejo D., Gherasim A. M., Delgado C., Oliva J., Casas I., Garcia M., Latorre M., Beamonte A. M. M., Sapina A. M., Amores M. O., Aizpurua A., Montes M., Zakikhany K., Brytting M., Wiman A., Carnahan A., Warburton F., Djennad A., Ellis J., Andrews N., Marques D., Cottrell S., Reynolds A., Gunson R., Galiano M., Lackenby A., Robertson C., O'Doherty M., Sinnathamby M., Yonova I., Moore C., Sartaj M., de Lusignan S., Zambon M., Moren A., Penttinen P.
المساهمون: Rondy, M., Kissling, E., Emborg, H. -D., Gherasim, A., Pebody, R., Trebbien, R., Pozo, F., Larrauri, A., Mcmenamin, J., Valenciano, M., Kaic, B., Filipovic, S. K., Visekruna-Vucina, V., Novosel, I. P., Lovric, Z., Petrovic, G., Krause, T. G., Fische, T. K., Lina, B., Falchi, A., Vilcu, A. -M., Souty, C., Blanchon, T., van der Werf, S., Enouf, V., Behillil, S., Valette, M., Bernard-Stoecklin, S., Levy-Bruhl, D., Launay, O., Loulergue, P., Lenzi, N., Lesieur, Z., L'Honneur, A. -S., Galtier, F., Agostini, C., Serrand, C., Merle, C., Foulongne, V., Vanhems, P., Laine, F., Lagathu, G., Carrat, F., Buda, S., Preuss, U., Prahm, K., Schweiger, B., Wedde, M., Heider, A., Martin, M., Biere, B., Duerrwald, R., Domegan, L., Coughlan, L., O'Donnell, J., Joyce, M., Collins, C., Dunford, L., Moran, J., Tuite, G., Duffy, M., Connell, J., de Gascun, C., Rizzo, C., Bella, A., Alfonsi, V., Castrucci, M. R., Puzelli, S., Pagani, E., Ghisetti, V., Pariani, E., Baldanti, F., Palu, G., D'Agaro, P., Ansaldi, F., Affanni, P., Rossolini, G. M., Camilloni, B., Bagnarelli, P., Sanguinetti, M., Atripaldi, L., Chironna, M., Serra, C., Vitale, F., Germinario, C., Orsi, A., Manini, I., Montomoli, E., Napoli, C., Orsi, G. B., Casado, I., Castilla, J., Fernandino, L., Martinez-Baz, I., Ezpeleta, G., Navascues, A., Perez-Garcia, A., Aguinaga, A., Ezpeleta, C.
سنة النشر: 2018
مصطلحات موضوعية: Europe, case control study, influenza, influenza vaccination, influenza vaccine effectivene, multicentre study, Adolescent, Adult, Aged, Child, Preschool, European Union, Female, Human, Infant, Newborn, Influenza A Virus, H1N1 Subtype, H3N2 Subtype, Influenza B viru, Influenza Vaccine, Male, Middle Aged, Pandemic, Treatment Outcome, Vaccination, Seasons
الوصف: Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age groups, 2017/18 influenza vaccine effectiveness was 25 to 52% against any influenza, 55 to 68% against influenza A(H1N1)pdm09, -42 to 7% against influenza A(H3N2) and 36 to 54% against influenza B. 2017/18 influenza vaccine should be promoted where influenza still circulates.
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000426471400001; volume:23; issue:9; firstpage:2; lastpage:13; numberofpages:12; journal:EUROSURVEILLANCE; http://hdl.handle.net/11388/227653Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85043760710; https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2018.23.9.18-00086Test
DOI: 10.2807/1560-7917.ES.2018.23.9.18-00086
الإتاحة: https://doi.org/10.2807/1560-7917.ES.2018.23.9.18-00086Test
http://hdl.handle.net/11388/227653Test
حقوق: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.10EA67C4
قاعدة البيانات: BASE
الوصف
DOI:10.2807/1560-7917.ES.2018.23.9.18-00086